1 Study Coverage 1.1 Human Rabies Immune Globulin (HRIG) Product Introduction 1.2 Market by Type 1.2.1 Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 200IU 1.2.3 500IU 1.3 Market by Application 1.3.1 Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Category II Exposure 1.3.3 Category III Exposure 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Human Rabies Immune Globulin (HRIG) Sales Estimates and Forecasts 2017-2028 2.2 Global Human Rabies Immune Globulin (HRIG) Revenue Estimates and Forecasts 2017-2028 2.3 Global Human Rabies Immune Globulin (HRIG) Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Human Rabies Immune Globulin (HRIG) Sales by Region 2.4.1 Global Human Rabies Immune Globulin (HRIG) Sales by Region (2017-2022) 2.4.2 Global Sales Human Rabies Immune Globulin (HRIG) by Region (2023-2028) 2.5 Global Human Rabies Immune Globulin (HRIG) Revenue by Region 2.5.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2022) 2.5.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Human Rabies Immune Globulin (HRIG) Sales by Manufacturers 3.1.1 Global Top Human Rabies Immune Globulin (HRIG) Manufacturers by Sales (2017-2022) 3.1.2 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Rabies Immune Globulin (HRIG) in 2021 3.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Manufacturers 3.2.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Manufacturers (2017-2022) 3.2.2 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Human Rabies Immune Globulin (HRIG) Revenue in 2021 3.3 Global Human Rabies Immune Globulin (HRIG) Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Human Rabies Immune Globulin (HRIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Human Rabies Immune Globulin (HRIG) Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Human Rabies Immune Globulin (HRIG) Sales by Type 4.1.1 Global Human Rabies Immune Globulin (HRIG) Historical Sales by Type (2017-2022) 4.1.2 Global Human Rabies Immune Globulin (HRIG) Forecasted Sales by Type (2023-2028) 4.1.3 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028) 4.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Type 4.2.1 Global Human Rabies Immune Globulin (HRIG) Historical Revenue by Type (2017-2022) 4.2.2 Global Human Rabies Immune Globulin (HRIG) Forecasted Revenue by Type (2023-2028) 4.2.3 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2017-2028) 4.3 Global Human Rabies Immune Globulin (HRIG) Price by Type 4.3.1 Global Human Rabies Immune Globulin (HRIG) Price by Type (2017-2022) 4.3.2 Global Human Rabies Immune Globulin (HRIG) Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Human Rabies Immune Globulin (HRIG) Sales by Application 5.1.1 Global Human Rabies Immune Globulin (HRIG) Historical Sales by Application (2017-2022) 5.1.2 Global Human Rabies Immune Globulin (HRIG) Forecasted Sales by Application (2023-2028) 5.1.3 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028) 5.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Application 5.2.1 Global Human Rabies Immune Globulin (HRIG) Historical Revenue by Application (2017-2022) 5.2.2 Global Human Rabies Immune Globulin (HRIG) Forecasted Revenue by Application (2023-2028) 5.2.3 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2017-2028) 5.3 Global Human Rabies Immune Globulin (HRIG) Price by Application 5.3.1 Global Human Rabies Immune Globulin (HRIG) Price by Application (2017-2022) 5.3.2 Global Human Rabies Immune Globulin (HRIG) Price Forecast by Application (2023-2028) 6 North America 6.1 North America Human Rabies Immune Globulin (HRIG) Market Size by Type 6.1.1 North America Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028) 6.1.2 North America Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2028) 6.2 North America Human Rabies Immune Globulin (HRIG) Market Size by Application 6.2.1 North America Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028) 6.2.2 North America Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2028) 6.3 North America Human Rabies Immune Globulin (HRIG) Market Size by Country 6.3.1 North America Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2028) 6.3.2 North America Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Human Rabies Immune Globulin (HRIG) Market Size by Type 7.1.1 Europe Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028) 7.1.2 Europe Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2028) 7.2 Europe Human Rabies Immune Globulin (HRIG) Market Size by Application 7.2.1 Europe Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028) 7.2.2 Europe Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2028) 7.3 Europe Human Rabies Immune Globulin (HRIG) Market Size by Country 7.3.1 Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2028) 7.3.2 Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Human Rabies Immune Globulin (HRIG) Market Size by Type 8.1.1 Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028) 8.1.2 Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2028) 8.2 Asia Pacific Human Rabies Immune Globulin (HRIG) Market Size by Application 8.2.1 Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028) 8.2.2 Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2028) 8.3 Asia Pacific Human Rabies Immune Globulin (HRIG) Market Size by Region 8.3.1 Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Region (2017-2028) 8.3.2 Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Human Rabies Immune Globulin (HRIG) Market Size by Type 9.1.1 Latin America Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028) 9.1.2 Latin America Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2028) 9.2 Latin America Human Rabies Immune Globulin (HRIG) Market Size by Application 9.2.1 Latin America Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028) 9.2.2 Latin America Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2028) 9.3 Latin America Human Rabies Immune Globulin (HRIG) Market Size by Country 9.3.1 Latin America Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2028) 9.3.2 Latin America Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Human Rabies Immune Globulin (HRIG) Market Size by Type 10.1.1 Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028) 10.1.2 Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2028) 10.2 Middle East and Africa Human Rabies Immune Globulin (HRIG) Market Size by Application 10.2.1 Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028) 10.2.2 Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2028) 10.3 Middle East and Africa Human Rabies Immune Globulin (HRIG) Market Size by Country 10.3.1 Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2028) 10.3.2 Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 CSL Behring 11.1.1 CSL Behring Corporation Information 11.1.2 CSL Behring Overview 11.1.3 CSL Behring Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 CSL Behring Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 CSL Behring Recent Developments 11.2 Grifols 11.2.1 Grifols Corporation Information 11.2.2 Grifols Overview 11.2.3 Grifols Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Grifols Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Grifols Recent Developments 11.3 Sanofi 11.3.1 Sanofi Corporation Information 11.3.2 Sanofi Overview 11.3.3 Sanofi Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Sanofi Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Sanofi Recent Developments 11.4 Sichuan Yuanda Shuyang 11.4.1 Sichuan Yuanda Shuyang Corporation Information 11.4.2 Sichuan Yuanda Shuyang Overview 11.4.3 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Sichuan Yuanda Shuyang Recent Developments 11.5 CNBG 11.5.1 CNBG Corporation Information 11.5.2 CNBG Overview 11.5.3 CNBG Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 CNBG Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 CNBG Recent Developments 11.6 Kamada 11.6.1 Kamada Corporation Information 11.6.2 Kamada Overview 11.6.3 Kamada Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Kamada Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Kamada Recent Developments 11.7 CBPO 11.7.1 CBPO Corporation Information 11.7.2 CBPO Overview 11.7.3 CBPO Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 CBPO Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 CBPO Recent Developments 11.8 Shuanglin Bio 11.8.1 Shuanglin Bio Corporation Information 11.8.2 Shuanglin Bio Overview 11.8.3 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Shuanglin Bio Recent Developments 11.9 Weiguang Bio 11.9.1 Weiguang Bio Corporation Information 11.9.2 Weiguang Bio Overview 11.9.3 Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Weiguang Bio Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Weiguang Bio Recent Developments 11.10 Shanghai RAAS 11.10.1 Shanghai RAAS Corporation Information 11.10.2 Shanghai RAAS Overview 11.10.3 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Shanghai RAAS Recent Developments 11.11 Bharat Serum 11.11.1 Bharat Serum Corporation Information 11.11.2 Bharat Serum Overview 11.11.3 Bharat Serum Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Bharat Serum Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Bharat Serum Recent Developments 11.12 VINS 11.12.1 VINS Corporation Information 11.12.2 VINS Overview 11.12.3 VINS Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 VINS Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 VINS Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Human Rabies Immune Globulin (HRIG) Industry Chain Analysis 12.2 Human Rabies Immune Globulin (HRIG) Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Human Rabies Immune Globulin (HRIG) Production Mode & Process 12.4 Human Rabies Immune Globulin (HRIG) Sales and Marketing 12.4.1 Human Rabies Immune Globulin (HRIG) Sales Channels 12.4.2 Human Rabies Immune Globulin (HRIG) Distributors 12.5 Human Rabies Immune Globulin (HRIG) Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Human Rabies Immune Globulin (HRIG) Industry Trends 13.2 Human Rabies Immune Globulin (HRIG) Market Drivers 13.3 Human Rabies Immune Globulin (HRIG) Market Challenges 13.4 Human Rabies Immune Globulin (HRIG) Market Restraints 14 Key Findings in The Global Human Rabies Immune Globulin (HRIG) Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of 200IU Table 3. Major Manufacturers of 500IU Table 4. Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global Human Rabies Immune Globulin (HRIG) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Human Rabies Immune Globulin (HRIG) Sales by Region (2017-2022) & (K Units) Table 7. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2017-2022) Table 8. Global Human Rabies Immune Globulin (HRIG) Sales by Region (2023-2028) & (K Units) Table 9. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2023-2028) Table 10. Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2022) & (US$ Million) Table 11. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2017-2022) Table 12. Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2023-2028) & (US$ Million) Table 13. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2023-2028) Table 14. Global Human Rabies Immune Globulin (HRIG) Sales by Manufacturers (2017-2022) & (K Units) Table 15. Global Human Rabies Immune Globulin (HRIG) Sales Share by Manufacturers (2017-2022) Table 16. Global Human Rabies Immune Globulin (HRIG) Revenue by Manufacturers (2017-2022) & (US$ Million) Table 17. Global Human Rabies Immune Globulin (HRIG) Revenue Share by Manufacturers (2017-2022) Table 18. Human Rabies Immune Globulin (HRIG) Price by Manufacturers (2017-2022) &(US$/Unit) Table 19. Global Human Rabies Immune Globulin (HRIG) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Human Rabies Immune Globulin (HRIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immune Globulin (HRIG) as of 2021) Table 21. Human Rabies Immune Globulin (HRIG) Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Human Rabies Immune Globulin (HRIG) Product Offered Table 23. Date of Manufacturers Enter into Human Rabies Immune Globulin (HRIG) Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units) Table 26. Global Human Rabies Immune Globulin (HRIG) Sales by Type (2023-2028) & (K Units) Table 27. Global Human Rabies Immune Globulin (HRIG) Sales Share by Type (2017-2022) Table 28. Global Human Rabies Immune Globulin (HRIG) Sales Share by Type (2023-2028) Table 29. Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2022) & (US$ Million) Table 30. Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2023-2028) & (US$ Million) Table 31. Global Human Rabies Immune Globulin (HRIG) Revenue Share by Type (2017-2022) Table 32. Global Human Rabies Immune Globulin (HRIG) Revenue Share by Type (2023-2028) Table 33. Human Rabies Immune Globulin (HRIG) Price by Type (2017-2022) & (US$/Unit) Table 34. Global Human Rabies Immune Globulin (HRIG) Price Forecast by Type (2023-2028) & (US$/Unit) Table 35. Global Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units) Table 36. Global Human Rabies Immune Globulin (HRIG) Sales by Application (2023-2028) & (K Units) Table 37. Global Human Rabies Immune Globulin (HRIG) Sales Share by Application (2017-2022) Table 38. Global Human Rabies Immune Globulin (HRIG) Sales Share by Application (2023-2028) Table 39. Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2022) & (US$ Million) Table 40. Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2023-2028) & (US$ Million) Table 41. Global Human Rabies Immune Globulin (HRIG) Revenue Share by Application (2017-2022) Table 42. Global Human Rabies Immune Globulin (HRIG) Revenue Share by Application (2023-2028) Table 43. Human Rabies Immune Globulin (HRIG) Price by Application (2017-2022) & (US$/Unit) Table 44. Global Human Rabies Immune Globulin (HRIG) Price Forecast by Application (2023-2028) & (US$/Unit) Table 45. North America Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units) Table 46. North America Human Rabies Immune Globulin (HRIG) Sales by Type (2023-2028) & (K Units) Table 47. North America Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2022) & (US$ Million) Table 48. North America Human Rabies Immune Globulin (HRIG) Revenue by Type (2023-2028) & (US$ Million) Table 49. North America Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units) Table 50. North America Human Rabies Immune Globulin (HRIG) Sales by Application (2023-2028) & (K Units) Table 51. North America Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2022) & (US$ Million) Table 52. North America Human Rabies Immune Globulin (HRIG) Revenue by Application (2023-2028) & (US$ Million) Table 53. North America Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022) & (K Units) Table 54. North America Human Rabies Immune Globulin (HRIG) Sales by Country (2023-2028) & (K Units) Table 55. North America Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022) & (US$ Million) Table 56. North America Human Rabies Immune Globulin (HRIG) Revenue by Country (2023-2028) & (US$ Million) Table 57. Europe Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units) Table 58. Europe Human Rabies Immune Globulin (HRIG) Sales by Type (2023-2028) & (K Units) Table 59. Europe Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2022) & (US$ Million) Table 60. Europe Human Rabies Immune Globulin (HRIG) Revenue by Type (2023-2028) & (US$ Million) Table 61. Europe Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units) Table 62. Europe Human Rabies Immune Globulin (HRIG) Sales by Application (2023-2028) & (K Units) Table 63. Europe Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2022) & (US$ Million) Table 64. Europe Human Rabies Immune Globulin (HRIG) Revenue by Application (2023-2028) & (US$ Million) Table 65. Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022) & (K Units) Table 66. Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2023-2028) & (K Units) Table 67. Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022) & (US$ Million) Table 68. Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2023-2028) & (US$ Million) Table 69. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units) Table 70. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Type (2023-2028) & (K Units) Table 71. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2022) & (US$ Million) Table 72. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Type (2023-2028) & (US$ Million) Table 73. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units) Table 74. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Application (2023-2028) & (K Units) Table 75. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2022) & (US$ Million) Table 76. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Application (2023-2028) & (US$ Million) Table 77. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Region (2017-2022) & (K Units) Table 78. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Region (2023-2028) & (K Units) Table 79. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2022) & (US$ Million) Table 80. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region (2023-2028) & (US$ Million) Table 81. Latin America Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units) Table 82. Latin America Human Rabies Immune Globulin (HRIG) Sales by Type (2023-2028) & (K Units) Table 83. Latin America Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2022) & (US$ Million) Table 84. Latin America Human Rabies Immune Globulin (HRIG) Revenue by Type (2023-2028) & (US$ Million) Table 85. Latin America Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units) Table 86. Latin America Human Rabies Immune Globulin (HRIG) Sales by Application (2023-2028) & (K Units) Table 87. Latin America Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2022) & (US$ Million) Table 88. Latin America Human Rabies Immune Globulin (HRIG) Revenue by Application (2023-2028) & (US$ Million) Table 89. Latin America Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022) & (K Units) Table 90. Latin America Human Rabies Immune Globulin (HRIG) Sales by Country (2023-2028) & (K Units) Table 91. Latin America Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022) & (US$ Million) Table 92. Latin America Human Rabies Immune Globulin (HRIG) Revenue by Country (2023-2028) & (US$ Million) Table 93. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2022) & (K Units) Table 94. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Type (2023-2028) & (K Units) Table 95. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2022) & (US$ Million) Table 96. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Type (2023-2028) & (US$ Million) Table 97. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2022) & (K Units) Table 98. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Application (2023-2028) & (K Units) Table 99. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2022) & (US$ Million) Table 100. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Application (2023-2028) & (US$ Million) Table 101. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2022) & (K Units) Table 102. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Country (2023-2028) & (K Units) Table 103. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2022) & (US$ Million) Table 104. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Country (2023-2028) & (US$ Million) Table 105. CSL Behring Corporation Information Table 106. CSL Behring Description and Major Businesses Table 107. CSL Behring Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 108. CSL Behring Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications Table 109. CSL Behring Recent Developments Table 110. Grifols Corporation Information Table 111. Grifols Description and Major Businesses Table 112. Grifols Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 113. Grifols Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications Table 114. Grifols Recent Developments Table 115. Sanofi Corporation Information Table 116. Sanofi Description and Major Businesses Table 117. Sanofi Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 118. Sanofi Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications Table 119. Sanofi Recent Developments Table 120. Sichuan Yuanda Shuyang Corporation Information Table 121. Sichuan Yuanda Shuyang Description and Major Businesses Table 122. Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 123. Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications Table 124. Sichuan Yuanda Shuyang Recent Developments Table 125. CNBG Corporation Information Table 126. CNBG Description and Major Businesses Table 127. CNBG Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 128. CNBG Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications Table 129. CNBG Recent Developments Table 130. Kamada Corporation Information Table 131. Kamada Description and Major Businesses Table 132. Kamada Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 133. Kamada Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications Table 134. Kamada Recent Developments Table 135. CBPO Corporation Information Table 136. CBPO Description and Major Businesses Table 137. CBPO Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 138. CBPO Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications Table 139. CBPO Recent Developments Table 140. Shuanglin Bio Corporation Information Table 141. Shuanglin Bio Description and Major Businesses Table 142. Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 143. Shuanglin Bio Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications Table 144. Shuanglin Bio Recent Developments Table 145. Weiguang Bio Corporation Information Table 146. Weiguang Bio Description and Major Businesses Table 147. Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 148. Weiguang Bio Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications Table 149. Weiguang Bio Recent Developments Table 150. Shanghai RAAS Corporation Information Table 151. Shanghai RAAS Description and Major Businesses Table 152. Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 153. Shanghai RAAS Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications Table 154. Shanghai RAAS Recent Developments Table 155. Bharat Serum Corporation Information Table 156. Bharat Serum Description and Major Businesses Table 157. Bharat Serum Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 158. Bharat Serum Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications Table 159. Bharat Serum Recent Developments Table 160. VINS Corporation Information Table 161. VINS Description and Major Businesses Table 162. VINS Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 163. VINS Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications Table 164. VINS Recent Developments Table 165. Key Raw Materials Lists Table 166. Raw Materials Key Suppliers Lists Table 167. Human Rabies Immune Globulin (HRIG) Distributors List Table 168. Human Rabies Immune Globulin (HRIG) Customers List Table 169. Human Rabies Immune Globulin (HRIG) Market Trends Table 170. Human Rabies Immune Globulin (HRIG) Market Drivers Table 171. Human Rabies Immune Globulin (HRIG) Market Challenges Table 172. Human Rabies Immune Globulin (HRIG) Market Restraints Table 173. Research Programs/Design for This Report Table 174. Key Data Information from Secondary Sources Table 175. Key Data Information from Primary Sources List of Figures Figure 1. Human Rabies Immune Globulin (HRIG) Product Picture Figure 3. Global Human Rabies Immune Globulin (HRIG) Market Share by Type in 2021 & 2028 Figure 3. 200IU Product Picture Figure 4. 500IU Product Picture Figure 5. Global Human Rabies Immune Globulin (HRIG) Market Share by Application in 2021 & 2028 Figure 6. Category II Exposure Figure 7. Category III Exposure Figure 8. Human Rabies Immune Globulin (HRIG) Report Years Considered Figure 9. Global Human Rabies Immune Globulin (HRIG) Sales 2017-2028 (K Units) Figure 10. Global Human Rabies Immune Globulin (HRIG) Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Human Rabies Immune Globulin (HRIG) Revenue 2017-2028 (US$ Million) Figure 12. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 13. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2017-2022) Figure 14. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2023-2028) Figure 15. North America Human Rabies Immune Globulin (HRIG) Sales YoY (2017-2028) & (K Units) Figure 16. North America Human Rabies Immune Globulin (HRIG) Revenue YoY (2017-2028) & (US$ Million) Figure 17. Europe Human Rabies Immune Globulin (HRIG) Sales YoY (2017-2028) & (K Units) Figure 18. Europe Human Rabies Immune Globulin (HRIG) Revenue YoY (2017-2028) & (US$ Million) Figure 19. Asia-Pacific Human Rabies Immune Globulin (HRIG) Sales YoY (2017-2028) & (K Units) Figure 20. Asia-Pacific Human Rabies Immune Globulin (HRIG) Revenue YoY (2017-2028) & (US$ Million) Figure 21. Latin America Human Rabies Immune Globulin (HRIG) Sales YoY (2017-2028) & (K Units) Figure 22. Latin America Human Rabies Immune Globulin (HRIG) Revenue YoY (2017-2028) & (US$ Million) Figure 23. Middle East & Africa Human Rabies Immune Globulin (HRIG) Sales YoY (2017-2028) & (K Units) Figure 24. Middle East & Africa Human Rabies Immune Globulin (HRIG) Revenue YoY (2017-2028) & (US$ Million) Figure 25. The Human Rabies Immune Globulin (HRIG) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 26. The Top 5 and 10 Largest Manufacturers of Human Rabies Immune Globulin (HRIG) in the World: Market Share by Human Rabies Immune Globulin (HRIG) Revenue in 2021 Figure 27. Global Human Rabies Immune Globulin (HRIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 28. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028) Figure 29. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2017-2028) Figure 30. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028) Figure 31. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2017-2028) Figure 32. North America Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028) Figure 33. North America Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2017-2028) Figure 34. North America Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028) Figure 35. North America Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2017-2028) Figure 36. North America Human Rabies Immune Globulin (HRIG) Sales Share by Country (2017-2028) Figure 37. North America Human Rabies Immune Globulin (HRIG) Revenue Share by Country (2017-2028) Figure 38. U.S. Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 39. Canada Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 40. Europe Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028) Figure 41. Europe Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2017-2028) Figure 42. Europe Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028) Figure 43. Europe Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2017-2028) Figure 44. Europe Human Rabies Immune Globulin (HRIG) Sales Share by Country (2017-2028) Figure 45. Europe Human Rabies Immune Globulin (HRIG) Revenue Share by Country (2017-2028) Figure 46. Germany Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 47. France Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 48. U.K. Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 49. Italy Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 50. Russia Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 51. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028) Figure 52. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2017-2028) Figure 53. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028) Figure 54. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2017-2028) Figure 55. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales Share by Region (2017-2028) Figure 56. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue Share by Region (2017-2028) Figure 57. China Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 58. Japan Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 59. South Korea Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 60. India Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 61. Australia Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 62. Taiwan Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 63. Indonesia Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 64. Thailand Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 65. Malaysia Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 66. Philippines Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 67. Latin America Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028) Figure 68. Latin America Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2017-2028) Figure 69. Latin America Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028) Figure 70. Latin America Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2017-2028) Figure 71. Latin America Human Rabies Immune Globulin (HRIG) Sales Share by Country (2017-2028) Figure 72. Latin America Human Rabies Immune Globulin (HRIG) Revenue Share by Country (2017-2028) Figure 73. Mexico Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 74. Brazil Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 75. Argentina Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 76. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028) Figure 77. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2017-2028) Figure 78. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028) Figure 79. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2017-2028) Figure 80. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales Share by Country (2017-2028) Figure 81. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue Share by Country (2017-2028) Figure 82. Turkey Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 83. Saudi Arabia Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 84. U.A.E Human Rabies Immune Globulin (HRIG) Revenue (2017-2028) & (US$ Million) Figure 85. Human Rabies Immune Globulin (HRIG) Value Chain Figure 86. Human Rabies Immune Globulin (HRIG) Production Process Figure 87. Channels of Distribution Figure 88. Distributors Profiles Figure 89. Bottom-up and Top-down Approaches for This Report Figure 90. Data Triangulation Figure 91. Key Executives Interviewed

CSL Behring Grifols Sanofi Sichuan Yuanda Shuyang CNBG Kamada CBPO Shuanglin Bio Weiguang Bio Shanghai RAAS Bharat Serum VINS